370 related articles for article (PubMed ID: 19734360)
1. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
[TBL] [Abstract][Full Text] [Related]
3. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
[TBL] [Abstract][Full Text] [Related]
5. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells.
Schlegel N; Waschke J
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C453-62. PubMed ID: 19118163
[TBL] [Abstract][Full Text] [Related]
6. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
[TBL] [Abstract][Full Text] [Related]
7. The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.
Irvine JC; Ganthavee V; Love JE; Alexander AE; Horowitz JD; Stasch JP; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(11):e44481. PubMed ID: 23144773
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.
Wang H; Kohr MJ; Traynham CJ; Ziolo MT
J Mol Cell Cardiol; 2009 Aug; 47(2):304-14. PubMed ID: 19345227
[TBL] [Abstract][Full Text] [Related]
9. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239.
Lindsay SL; Ramsey S; Aitchison M; Renné T; Evans TJ
J Cell Sci; 2007 Sep; 120(Pt 17):3011-21. PubMed ID: 17684063
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
11. A VASP-Rac-soluble guanylyl cyclase pathway controls cGMP production in adipocytes.
Jennissen K; Siegel F; Liebig-Gonglach M; Hermann MR; Kipschull S; van Dooren S; Kunz WS; Fässler R; Pfeifer A
Sci Signal; 2012 Aug; 5(239):ra62. PubMed ID: 22932701
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats.
Schäfer A; Flierl U; Kobsar A; Eigenthaler M; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2813-8. PubMed ID: 17023677
[TBL] [Abstract][Full Text] [Related]
13. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
Holt AW; Martin DN; Shaver PR; Adderley SP; Stone JD; Joshi CN; Francisco JT; Lust RM; Weidner DA; Shewchuk BM; Tulis DA
Cell Signal; 2016 Sep; 28(9):1364-1379. PubMed ID: 27302407
[TBL] [Abstract][Full Text] [Related]
15. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
16. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.
Patrizio M; Vago V; Musumeci M; Fecchi K; Sposi NM; Mattei E; Catalano L; Stati T; Marano G
J Mol Cell Cardiol; 2008 Dec; 45(6):761-9. PubMed ID: 18851973
[TBL] [Abstract][Full Text] [Related]
17. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
[TBL] [Abstract][Full Text] [Related]
18. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
[TBL] [Abstract][Full Text] [Related]
19. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
[TBL] [Abstract][Full Text] [Related]
20. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
